Ledger.Open graph →
SEC Form D · filed June 6, 2023

Carmot Therapeutics Inc

Offering
$150.0M
Sold
$150.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BERKELEY, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Tim K. Kutzkey · Berkeley, CADirectorPeter K. Svennilson · Berkeley, CADirectorAetna Wun K. Trombley · Berkeley, CADirectorAnne K. Phillips, M.D · Berkeley, CADirectorTimothy K. Garnett · Berkeley, CADirectorStig K. Hansen, Ph.D · Berkeley, CADirectorHeather K. Turner · Berkeley, CAExec · DirectorAnne K. Phillips, M.D · Berkeley, CADirectorTim K. Kutzkey · Berkeley, CADirectorPeter K. Svennilson · Berkeley, CADirectorAetna Wun K. Trombley · Berkeley, CADirectorTimothy K. Garnett · Berkeley, CADirectorStig K. Hansen, Ph.D · Berkeley, CADirectorHeather K. Turner · Berkeley, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗